Cargando…
EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma
Cleavage of erythropoietin-producing hepatocellular ephrin receptor A2 (EphA2) triggers malignant progression and yields an N-terminal fragment (EphA2-NF) detectable in sera from patients with pancreatic ductal carcinoma. We established a quantitative automated chemiluminescence immunoassay for EphA...
Autores principales: | Sato, Shinya, Nakagawa, Masatoshi, Terashima, Takeshi, Morinaga, Soichiro, Miyagi, Yohei, Yoshida, Eisaku, Yoshimura, Toru, Seiki, Motoharu, Kaneko, Shuichi, Ueno, Makoto, Yamashita, Taro, Koshikawa, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503484/ https://www.ncbi.nlm.nih.gov/pubmed/37712876 http://dx.doi.org/10.1158/2767-9764.CRC-23-0087 |
Ejemplares similares
-
Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer
por: Koshikawa, Naohiko, et al.
Publicado: (2017) -
Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review
por: Yasuda, Hiroshi, et al.
Publicado: (2019) -
Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer
por: Nakagawa, Masatoshi, et al.
Publicado: (2017) -
Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma
por: Asakura, Nobuhiko, et al.
Publicado: (2021) -
Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022)